Never-Before-Seen Data on the Injectable Drugs Market Now Available through DoseData

As hospitals and their pharmacy operations continue to evolve in the wake of the COVID-19 pandemic, participants across the healthcare ecosystem have intensified their focus on supply chain digitization.

Using a proprietary RFID-tagged drug database, DoseData's tagged product report provides a rich understanding of drug consumption, including medications sourced from the 503B channel.

Updated daily, the report ingests its data directly from hospital inventory systems which catalog real-time drug consumption.

In addition to detailing which specific drug was used, the report also includes rich meta-data which facilitates detailed analysis based on manufacturer name and type, package size and type, concentration, and specific drug. This data illuminates a part of the supply chain that generic drug manufacturers and 503b compounders can use to help address market needs on both an ongoing basis, and when responding to critical supply chain disruptions such as shortages.